La Katana is a modern hybrid whose precise origins remain undocumented and thinly sourced. Breeders have not publicly confirmed the specific cross, and though Llimonet Haze is cited as a parent, the full lineage is incomplete. Because no established firm has claimed the development of this variety, its history remains unverified, and any claims regarding its provenance should be viewed as speculative. Despite the lack of an official breeding record, it is cultivated in both indoor and outdoor environments, where it demonstrates a moderate level of difficulty and achieves a high yield within a 56-day flowering period.

The sensory profile of La Katana is defined by an abundant presence of terpinolene, followed closely by myrcene, ocimene, and caryophyllene. The full chemical architecture continues through beta-pinene, limonene, pinene, alpha-terpinene, gamma-terpinene, humulene, eucalyptol, and nerolidol. While the specific concentration of these compounds is subject to variation, the overall fragrance and flavor are characterized by this complex array of terpenes. The strain contains an estimated 22.1% THC and an estimated 0% CBD, providing a profile consistent with modern high-potency hybrid varieties.

Users of La Katana typically experience effects described as relaxed, happy, and uplifted. These characteristics make it a frequent choice for managing stress and physical pain, as well as for addressing difficulty with sleep. While it serves as a functional tool for these specific therapeutic use cases, there are no recorded notable offspring currently associated with the strain. Its pharmacological impact remains centered on its verified cannabinoid and terpene content, offering a consistent experience for those seeking a balanced, uplifting hybrid.